•  
  •  
  •  
  •  

2023-03-24 02:26:31

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • W S Industries India Ltd approves availing of short term loans
  • SBI completes acquisition of 40% stake of Canara Bank in Commercial Indo Bank LLC
  • Indigenous Casting Technology Pvt Ltd becomes 100% subsidiary of NIBE Ltd
  • R.P.P Infra Projects Wins a New Order Worth INR 104.79 Crores
  • Healthcare Triangle to Participate in ViVE 2023 as Presenter and Sponsor

Keywords Selected:  ACE

Research

  • Company Update - P&G Health - ICICI Direct
  • Profits on Housing Investment - Past, Present, and Future
  • Coworking Share in Office Real Estate at 20% in H1 2022 from 6% in 2021
  • Over 45 Data Centres Spanning ~13 Mn Sft to Boot Up in India by 2025-end
  • Why Commercial Real Estate Investors are betting on Office Spaces
  • ICRA's sample set of Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
  • Initiating Coverage - Hindustan Aeronautics Ltd - ICICI Direct
  • UltraTech Cement - Cost escalations getting passed on QoQ - ICICI Securities
  • Ambuja Cements - 1QCY22 Result Update - Realization Falters, but Volume and EBITDA Beat
  • Ambuja Cement - Cost controls lift margin QoQ - HDFC Securities
  • Company Update - Mahindra Lifespace Developers - ICICI Direct
  • Ambuja Cements - Improved margins over sequential cost decline - YES Securities
  • Ambuja Cement - Q1CY22 Result Update - Beat on estimates; Clarity on Holcim's exit holds the key - Downgrade to 'HOLD'
  • Mahindra Lifespaces - Outperformance continues - HDFC Securities
  • Mahindra Lifespace Developers - Well poised for growth - ICICI Securities
  • Ambuja Cement - Q1CY22 First Cut - ICICI Direct
  • Ambuja Cements - 4QCY21 Result Update - Cost Pressure Led to EBITDA Miss
  • Kajaria Ceramics - Q3FY22 First Cut - ICICI Direct
  • Ultratech Cement - 3QFY22 Result Update - Soft Quarter - Margins Seem to Have Bottomed Out
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities
  • Maintain BUY on UltraTech Cement - Strong demand moderates impact of cost inflation - HDFC Securities

IPO News

  • Penna Cement gets Sebi nod for Rs 1,550 crore IPO

Stock Report

  • BrahMos Missile Checkout Equipment unveiled at Data Patterns
  • Sansera Engineering Ltd Certified as a Great Place to Work
  • IDFC FIRST Bank approves allotment of 37,75,00,859 shares
  • Mastek Earns 2023 'Great Place to Work' Certification
  • Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam
  • Government announces OFS in Hindustan Aeronautics Ltd
  • Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study
  • RaiITel Corporation of India Ltd receives Rs. 34.91 crores order
  • InfoBeans Technologies Ltd recognized as 'Great Place to Work for 2023'
  • Zydus receives final and tentative Approval from the USFDA for Tofacitinib Tablets, 5 mg and 10 mg
  • Granules Consumer Health Inc., concludes FDA Audit with Zero Observations
  • Zydus granted Orphan Drug Designation by the USFDA for ZYIL1 in treatment of patients with Cryopyrin Associated Periodic Syndrome
  • HGS Canada Certified as a Great Place to Work® for 2023-2024
  • Unichem Laboratories Ltd appoints Ms. Priti Puri as additional independent director
  • Paras Defence and Space Technologies Ltd wins contract for Avionics Suite for Saras MK-2 Aircraft
  • Glenmark Pharmaceuticals receives ANDA approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg
  • The Federal Bank Ltd to raise Rs. 1000 crores
  • Achyut Healthcare Ltd recommends 1:2 bonus issue
  • USFDA Pre-Approval Inspection of Oral Oncology Manufacturing facility, Gujarat
  • Indian Coast Guard to get Advance Light Helicopters MK-III from HAL
  • Glenmark receives acceptance from U.S. FDA for Phase 1/2, first-in-human clinical study of GRC 54276
  • RACL Geartech Ltd certified as Great Workplace
  • Paras Defence and Space Technologies Ltd to form JV with Israel firm
  • Vedanta Aluminium & Dalmia Cement partner for manufacturing low-carbon cement

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India
  • As Offices are Reopening, Investing in commercial assets might be a lucrative deal
  • Want to save Construction cost? Follow these seven tips
  • SIDBI joins hands with UPEIDA to support MSMEs in Aerospace & Defence sector

Latest Post

  • W S Industries India Ltd approves availing of short term loans
  • SBI completes acquisition of 40% stake of Canara Bank in Commercial Indo Bank LLC
  • Indigenous Casting Technology Pvt Ltd becomes 100% subsidiary of NIBE Ltd
  • R.P.P Infra Projects Wins a New Order Worth INR 104.79 Crores
  • Healthcare Triangle to Participate in ViVE 2023 as Presenter and Sponsor


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2022